Elvia Cowan, SVP, FINANCE at Vaxcyte, Inc. (PCVX), sold 6,145 shares at $107.67 ($664K) on 2024-09-03, disclosed to the SEC on 2024-09-05.
Scheduled sale ($664k) by SVP, FINANCE under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $107.67 | 5,000 | $538K | 81.0% |
| 2 | $110.15 | 1,145 | $126K | 19.0% |
| Total | $108.13 avg | 6,145 | $664K | 100% |
| Filing → |
| PCVX | SELL | 2026-03-18 | $210K | — | Filing → |
| PCVX | SELL | 2026-03-11 | $293K | — | Filing → |
| PCVX | SELL | 2025-12-29 | $1.1M | — | Filing → |